-
Section IPS Medication Summary Section (2.16.840.1.113883.10.22.3.1)
-
Entry IPS Body Author (2.16.840.1.113883.10.22.4.14)
-
Entry IPS CDA Device (2.16.840.1.113883.10.22.9.2)
-
Entry CDA Informant (Body) (2.16.840.1.113883.10.12.319)
-
* CDA AssignedEntity (2.16.840.1.113883.10.12.153)
-
* CDA Person (2.16.840.1.113883.10.12.152)
-
* CDA Organization (2.16.840.1.113883.10.12.151)
-
Entry CDA RelatedEntity (2.16.840.1.113883.10.12.316)
-
* CDA Person (2.16.840.1.113883.10.12.152)
-
Entry IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
-
Entry UV Use Period (2.16.840.1.113883.10.21.9.1)
-
Entry IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
-
Entry IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
-
Entry IPS Body Author (2.16.840.1.113883.10.22.4.14)
-
Entry IPS CDA Device (2.16.840.1.113883.10.22.9.2)
-
Entry UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
-
Section IPS Translation Section (2.16.840.1.113883.10.22.3.15)
|